Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.

JCO oncology practice·2026
Same author

Whole-protein screening and multi-modal profiling of antigen-specific CD4<sup>+</sup> T cells at single-cell resolution.

Nature communications·2026
Same author

MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Cellular neighborhoods govern antitumor T-cell infiltration following anti-CTLA-4 in melanoma with primary resistance to anti-PD-1.

Cancer discovery·2026
Same author

Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancer.

Nature communications·2026
Same author

First-in-Human Phase I Study of KPT-9274, a First-in-Class Dual Inhibitor of PAK4 and NAMPT, in Patients with Advanced Solid Malignancies.

Targeted oncology·2026

Related Experiment Video

Updated: Mar 28, 2026

A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells
15:41

A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells

Published on: October 15, 2013

15.6K

Single-cell analysis tools for drug discovery and development.

James R Heath1, Antoni Ribas2, Paul S Mischel3

  • 1California Institute of Technology Division of Chemistry and Chemical Engineering, MC 127-72, 1200 East California Boulevard, Pasadena, California 91125, USA.

Nature Reviews. Drug Discovery
|December 17, 2015
PubMed
Summary
This summary is machine-generated.

Tissue heterogeneity complicates drug discovery. Single-cell analysis tools offer solutions for genomic, transcriptomic, and proteomic studies, improving disease models and therapy response prediction.

More Related Videos

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

6.0K
A Versatile Automated Platform for Micro-scale Cell Stimulation Experiments
12:21

A Versatile Automated Platform for Micro-scale Cell Stimulation Experiments

Published on: August 6, 2013

11.1K

Related Experiment Videos

Last Updated: Mar 28, 2026

A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells
15:41

A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells

Published on: October 15, 2013

15.6K
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

6.0K
A Versatile Automated Platform for Micro-scale Cell Stimulation Experiments
12:21

A Versatile Automated Platform for Micro-scale Cell Stimulation Experiments

Published on: August 6, 2013

11.1K

Area of Science:

  • Biomedical Research
  • Genomics
  • Proteomics

Background:

  • Tissue heterogeneity poses significant challenges in drug discovery and development.
  • This complexity impacts the creation of accurate disease models and the interpretation of patient treatment outcomes.
  • Understanding cellular diversity is crucial for advancing precision medicine.

Purpose of the Study:

  • To review single-cell analysis tools for genomic, transcriptomic, and proteomic applications.
  • To assess the advantages and limitations of these cutting-edge technologies.
  • To discuss emerging applications in drug discovery, especially in oncology.

Main Methods:

  • Review of existing literature on single-cell analysis technologies.
  • Comparative assessment of genomic, transcriptomic, and proteomic single-cell methods.
  • Analysis of case studies in drug discovery and oncology.

Main Results:

  • Single-cell analyses provide unprecedented resolution into tissue composition.
  • These tools overcome limitations of bulk analysis in capturing cellular heterogeneity.
  • Specific techniques show promise in identifying novel therapeutic targets and patient stratification biomarkers.

Conclusions:

  • Single-cell analysis tools are essential for overcoming challenges in drug discovery posed by tissue heterogeneity.
  • These methods enhance the development of more accurate disease models and personalized therapies.
  • Further integration of single-cell approaches, particularly in oncology, will accelerate therapeutic innovation.